Annotated Medicine and Device Lists

Daclatasvir

Tablet 30 mg (as hydrochloride). Tablet 60 mg (as hydrochloride). Tablet 30 mg Tablet 60 mg

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.4.2.1 Pangenotypic direct-acting antiviral combinations	Others observations: Pangenotypic when used in combination with sofosbuvir

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.4.2.1 Pangenotypic direct-acting antiviral combinations	Others observations: Pangenotypic when used in combination with sofosbuvir

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.6.4.2. Medicines for Hepatitis C	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.6.4.2. Medicines for Hepatitis C	No observations

Information Resources: Daclatasvir

No information available